Suzhou Ribo Life Science Co., Ltd. (HKG:6938)

Hong Kong · Delayed Price · Currency is HKD

57.05

-0.65 (-1.13%)

Sep 10, 2026, 11:59 AM HKT

Suzhou Ribo Life Science Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Debt / Equity Ratio	0.30	20.55	-3.86	3.58	0.24	-
Net Debt / Equity Ratio	-0.94	5.29	-2.19	1.72	-0.52	-0.44
Net Debt / EBITDA Ratio	21.60	-0.59	-1.11	-0.53	1.33	1.10
Net Debt / FCF Ratio	-	-0.49	-2.90	-0.61	1.12	0.94
Asset Turnover	0.24	0.20	0.21	-	-	-
Inventory Turnover	0.65	0.55	0.61	-	0.13	0.29
Quick Ratio	4.91	0.74	0.53	0.77	2.18	4.02
Current Ratio	5.29	0.86	0.65	0.94	2.55	4.71
Return on Equity (ROE)	-17.59%	-	-12091.58%	-	-48.77%	-41.96%
Return on Assets (ROA)	-3.85%	-23.42%	-23.62%	-	-25.04%	-26.12%
Return on Capital Employed (ROCE)	-5.00%	-117.20%	-109.20%	-108.80%	-43.60%	-46.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Buyback Yield / Dilution	-16.57%	-2.55%	-0.19%	-330.71%	-10.22%	-10.39%